1,293 results on '"Muhlestein, Joseph B."'
Search Results
252. Associations Between Chronic Kidney Disease and Outcomes With Use of Prasugrel Versus Clopidogrel in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
253. Impact of Selection Bias on Estimation of Subsequent Event Risk
254. The association of depression at any time to the risk of death following coronary artery disease diagnosis
255. THE ASSOCIATION OF DEPRESSION AT ANY TIME TO THE RISK OF DEATH FOLLOWING CORONARY ARTERY DISEASE DIAGNOSIS: THE INTERMOUNTAIN INSPIRE REGISTRY
256. Primary Prevention of CVD
257. CIRCULATING MICRORNA PATTERNS ARE ASSOCIATED WITH POST-ABLATION RECURRENCE OF ATRIAL FIBRILLATION
258. IMPROVEMENT OF CHA2DS2-VASC RISK STRATIFICATION OF STROKE AND MORTALITY USING THE INTERMOUNTAIN RISK SCORE AMONG ATRIAL FIBRILLATION PATIENTS UNDERGOING CARDIAC CATHETERIZATION
259. PREDICTING 3-YEAR RISK OF INCIDENT CHRONIC DISEASE IN DISEASE-FREE PRIMARY CARE PATIENTS: THE INTERMOUNTAIN CHRONIC DISEASE MODEL (ICHRON)
260. The association of antidepressant and statin use with death and incident cardiovascular disease varies by depression severity
261. The role of microRNAs in the development, regulation, and treatment of atrial fibrillation.
262. Effects of Evolocumab on the ApoA1 Remnant Ratio: A Pooled Analysis of Phase 3 Studies.
263. CHA2DS2-VASc scores and Intermountain Mortality Risk Scores for the joint risk stratification of dementia among patients with atrial fibrillation.
264. Intermittent fasting and changes in clinical risk scores: Secondary analysis of a randomized controlled trial
265. Do infections cause coronary disease? The evidence implicating Chlamydia pneumoniae
266. Angiographic follow-up after internal mammary artery graft angioplasty
267. Is the Association of Statin Use and Incident Diabetes Mellitus Still Significant in Primary Prevention Treatment When Accounting for Incident Cardiovascular Events?
268. Abstract 12443: Incident Heart Failure Risk After Acute Myocardial Infarction is Stratified by the Intermountain Major Adverse Cardiovascular Events (IMACE) Risk Scores
269. Abstract 12529: The Association of the Different Vitamin D Metabolites to Death, Myocardial Infarction, Heart Failure, and Stroke: Results From the Intermountain Heart Collaborative Study
270. Abstract 12215: Objective Stratification of Six-Month Mortality Risk among Patients Referred to Hospice
271. Utility of high density lipoprotein particle concentration in predicting future major adverse cardiovascular events among patients undergoing angiography
272. Long-term influence of body mass index on cardiovascular events after atrial fibrillation ablation
273. Impact of Testosterone Replacement Therapy on Myocardial Infarction, Stroke, and Death in Men With Low Testosterone Concentrations in an Integrated Health Care System
274. Adverse cardiovascular events in acute coronary syndrome with indications for anticoagulation
275. Improvement in the predictive ability of the Intermountain Mortality Risk Score by adding routinely collected laboratory tests such as albumin, bilirubin, and white cell differential count
276. Short‐Term Exposure to Fine Particulate Matter Air Pollution Is Preferentially Associated With the Risk of ST‐Segment Elevation Acute Coronary Events
277. Long-Term Natural History of Adult Wolff–Parkinson–White Syndrome Patients Treated With and Without Catheter Ablation
278. Improving CHA2DS2-VASc stratification of non-fatal stroke and mortality risk using the Intermountain Mortality Risk Score among patients with atrial fibrillation.
279. Abstract 15149: Short-term Exposure to Fine Particulate Matter Air Pollution Preferentially Increases the Risk of ST-Elevation Acute Coronary Events
280. Abstract 16401: Cardiovascular Clinical Effects of Testosterone Supplementation Among Healthy Hypo-androgenic Men: Information From the Intermountain Healthcare Health Plans Database
281. Abstract 14717: Identifying Predictors of Red Cell Distribution Width at Admission and Changes in RDW During Heart Failure Hospitalization
282. Abstract 15117: Undiagnosed Diabetes at the Time of Acute Myocardial Infarction is Frequent and Associated With Poor Cardiovascular Outcomes
283. Abstract 14907: Clinically Feasible Electronic Health Record Tool for Stratification of 1- to 3-Year Post-Myocardial Infarction Risk of Cardiovascular Events: The Intermountain Acute Coronary Syndromes Risk Scores
284. Abstract 18102: Threshold Effect of Vitamin D Deficiency on Cardiovascular Outcomes: Below What Level of 25(OH) Vitamin D is Cardiovascular Risk Really Increased?
285. Abstract 16347: The Association of Depressive Symptoms and the Intermountain Mortality Risk Score to All-cause Mortality
286. Abstract 16045: Is Low Dose Beta Blocker Equivalent to High Dose for Reducing Major Adverse Cardiovascular Events?
287. Abstract 16122: Is Vitamin D Deficiency Really Associated With an Increased Incidence of Statin Intolerance?
288. The utility of the apolipoprotein A1 remnant ratio in predicting incidence coronary heart disease in a primary prevention cohort: The Jackson Heart Study
289. TCT-219 Impact of prasugrel versus clopidogrel in ACS patients undergoing PCI with short or long stents: Results from the PROMETHEUS Study
290. TCT-220 Effect of prasugrel versus clopidogrel in ACS patients with high or low BMI undergoing PCI: Results from the PROMETHEUS Study
291. TCT-221 Impact of prasugrel versus clopidogrel in smokers and non-smokers undergoing PCI for ACS: Results from the PROMETHEUS Study
292. TCT-487 Temporal Associations Between Myocardial Infarction, Major Bleeding and Mortality Risk in ACS Patients Undergoing PCI: Insights from the PROMETHEUS Cohort
293. Health effects of intermittent fasting: hormesis or harm? A systematic review
294. Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies
295. Association of the dispersion in red blood cell volume with mortality
296. Letter by Horne et al Regarding Article, “Prognostic Value of Fasting Versus Nonfasting Low-Density Lipoprotein Cholesterol Levels on Long-Term Mortality: Insight From the National Health and Nutrition Survey III (NHANES-III)”
297. Pulmonary-Specific Intermountain Risk Score Predicts All-Cause Mortality via Spirometry, the Red Cell Distribution Width, and Other Laboratory Parameters
298. The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation
299. Coronary Artery Disease Screening Using Coronary Computed Tomography Angiography—Reply
300. Novel Stratification of Mortality Risk by Kidney Disease Stage
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.